Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis
- 8 July 2008
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 105 (27), 9367-9372
- https://doi.org/10.1073/pnas.0709578105
Abstract
Zygomycosis is an emerging frequently fatal opportunistic mycosis whose immunopathogenesis is poorly understood. We developed a zygomycosis model by injecting Drosophila melanogaster flies with a standardized amount of fungal spores from clinical Zygomycetes isolates to study virulence and host defense mechanisms. We found that, as opposed to most other fungi, which are nonpathogenic in D. melanogaster (e.g., Aspergillus fumigatus), Zygomycetes rapidly infect and kill wild-type flies. Toll-deficient flies exhibited increased susceptibility to Zygomycetes, whereas constitutive overexpression of the antifungal peptide Drosomycin in transgenic flies partially restored resistance to zygomycosis. D. melanogaster Schneider 2 phagocytic cells displayed decreased phagocytosis and caused less hyphal damage to Zygomycetes compared with that to A. fumigatus. Furthermore, phagocytosis-defective eater mutant flies displayed increased susceptibility to Zygomycetes infection. Classic enhancers of Zygomycetes virulence in humans, such as corticosteroids, increased iron supply, and iron availability through treatment with deferoxamine dramatically increased Zygomycetes pathogenicity in our model. In contrast, iron starvation induced by treatment with the iron chelator deferasirox significantly protected flies infected with Zygomycetes. Whole-genome expression profiling in wild-type flies after infection with Zygomycetes vs. A. fumigatus identified genes selectively down-regulated by Zygomycetes, which act in pathogen recognition, immune defense, stress response, detoxification, steroid metabolism, or tissue repair or have unknown functions. Our results provide insights into the factors that mediate host-pathogen interactions in zygomycosis and establish D. melanogaster as a promising model to study this important mycosis.This publication has 43 references indexed in Scilit:
- Drosomycin-Like Defensin, a Human Homologue ofDrosophila melanogasterDrosomycin with Antifungal ActivityAntimicrobial Agents and Chemotherapy, 2008
- Involvement of Skeletal Muscle Gene Regulatory Network in Susceptibility to Wound Infection Following TraumaPLOS ONE, 2007
- The iron chelator deferasirox protects mice from mucormycosis through iron starvationJCI Insight, 2007
- Homeostatic Mechanisms for Iron Storage Revealed by Genetic Manipulations and Live Imaging of Drosophila FerritinGenetics, 2007
- Drosophila melanogaster Thor and Response to Candida albicans InfectionEukaryotic Cell, 2007
- A Specific Primed Immune Response in Drosophila Is Dependent on PhagocytesPLoS Pathogens, 2007
- Dual Detection of Fungal Infections in Drosophila via Recognition of Glucans and Sensing of Virulence FactorsCell, 2006
- Rel/NF-κB double mutants reveal that cellular immunity is central to Drosophila host defenseProceedings of the National Academy of Sciences of the United States of America, 2006
- Prevalence of Local Immune Response against Oral Infection in a Drosophila/Pseudomonas Infection ModelPLoS Pathogens, 2006
- Identification of Drosophila Gene Products Required for Phagocytosis of Candida albicansPLoS Biology, 2005